166 related articles for article (PubMed ID: 21800344)
41. Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cells.
Höpfner M; Huether A; Sutter AP; Baradari V; Schuppan D; Scherübl H
Biochem Pharmacol; 2006 May; 71(10):1435-48. PubMed ID: 16530734
[TBL] [Abstract][Full Text] [Related]
42. Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma.
Fleischer B; Schulze-Bergkamen H; Schuchmann M; Weber A; Biesterfeld S; Müller M; Krammer PH; Galle PR
Int J Oncol; 2006 Jan; 28(1):25-32. PubMed ID: 16327976
[TBL] [Abstract][Full Text] [Related]
43. TGF-β-independent CTGF induction regulates cell adhesion mediated drug resistance by increasing collagen I in HCC.
Song Y; Kim JS; Choi EK; Kim J; Kim KM; Seo HR
Oncotarget; 2017 Mar; 8(13):21650-21662. PubMed ID: 28423507
[TBL] [Abstract][Full Text] [Related]
44. Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration.
Haskins JW; Nguyen DX; Stern DF
Sci Signal; 2014 Dec; 7(355):ra116. PubMed ID: 25492965
[TBL] [Abstract][Full Text] [Related]
45. miR-133b Regulation of Connective Tissue Growth Factor: A Novel Mechanism in Liver Pathology.
Gjymishka A; Pi L; Oh SH; Jorgensen M; Liu C; Protopapadakis Y; Patel A; Petersen BE
Am J Pathol; 2016 May; 186(5):1092-102. PubMed ID: 26945106
[TBL] [Abstract][Full Text] [Related]
46. Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development.
Uriarte I; Latasa MU; Carotti S; Fernandez-Barrena MG; Garcia-Irigoyen O; Elizalde M; Urtasun R; Vespasiani-Gentilucci U; Morini S; de Mingo A; Mari M; Corrales FJ; Prieto J; Berasain C; Avila MA
Int J Cancer; 2015 May; 136(10):2469-75. PubMed ID: 25346390
[TBL] [Abstract][Full Text] [Related]
47. CTGF secreted by mesenchymal-like hepatocellular carcinoma cells plays a role in the polarization of macrophages in hepatocellular carcinoma progression.
Wang TT; Yuan JH; Ma JZ; Yang WJ; Liu XN; Yin YP; Liu Y; Pan W; Sun SH
Biomed Pharmacother; 2017 Nov; 95():111-119. PubMed ID: 28837877
[TBL] [Abstract][Full Text] [Related]
48. STAT3 is Activated by CTGF-mediated Tumor-stroma Cross Talk to Promote HCC Progression.
Makino Y; Hikita H; Kato S; Sugiyama M; Shigekawa M; Sakamoto T; Sasaki Y; Murai K; Sakane S; Kodama T; Sakamori R; Kobayashi S; Eguchi H; Takemura N; Kokudo N; Yokoi H; Mukoyama M; Tatsumi T; Takehara T
Cell Mol Gastroenterol Hepatol; 2023; 15(1):99-119. PubMed ID: 36210625
[TBL] [Abstract][Full Text] [Related]
49. TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth.
Fujii M; Toyoda T; Nakanishi H; Yatabe Y; Sato A; Matsudaira Y; Ito H; Murakami H; Kondo Y; Kondo E; Hida T; Tsujimura T; Osada H; Sekido Y
J Exp Med; 2012 Mar; 209(3):479-94. PubMed ID: 22329991
[TBL] [Abstract][Full Text] [Related]
50. SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma.
Mao B; Hu F; Cheng J; Wang P; Xu M; Yuan F; Meng S; Wang Y; Yuan Z; Bi W
Oncogene; 2014 Mar; 33(11):1468-74. PubMed ID: 23542177
[TBL] [Abstract][Full Text] [Related]
51. Reduced expression of epidermal growth factor receptor-related protein in hepatocellular carcinoma: implications for cancer growth.
Moon WS; Chang KJ; Majumdar AP; Tarnawski AS
Digestion; 2004; 69(4):219-24. PubMed ID: 15205570
[TBL] [Abstract][Full Text] [Related]
52. Connective tissue growth factor and β-catenin constitute an autocrine loop for activation in rat sarcomatoid mesothelioma.
Jiang L; Yamashita Y; Chew SH; Akatsuka S; Ukai S; Wang S; Nagai H; Okazaki Y; Takahashi T; Toyokuni S
J Pathol; 2014 Aug; 233(4):402-14. PubMed ID: 24839947
[TBL] [Abstract][Full Text] [Related]
53. Oncogenic Determination of a Broad Spectrum of Phenotypes of Hepatocyte-Derived Mouse Liver Tumors.
Yamamoto M; Xin B; Watanabe K; Ooshio T; Fujii K; Chen X; Okada Y; Abe H; Taguchi Y; Miyokawa N; Furukawa H; Nishikawa Y
Am J Pathol; 2017 Dec; 187(12):2711-2725. PubMed ID: 28964793
[TBL] [Abstract][Full Text] [Related]
54. NUP37, a positive regulator of YAP/TEAD signaling, promotes the progression of hepatocellular carcinoma.
Luo X; Liu Y; Feng W; Lei L; Du Y; Wu J; Wang S
Oncotarget; 2017 Nov; 8(58):98004-98013. PubMed ID: 29228669
[TBL] [Abstract][Full Text] [Related]
55. A CTGF-YAP Regulatory Pathway Is Essential for Angiogenesis and Barriergenesis in the Retina.
Moon S; Lee S; Caesar JA; Pruchenko S; Leask A; Knowles JA; Sinon J; Chaqour B
iScience; 2020 Jun; 23(6):101184. PubMed ID: 32502964
[TBL] [Abstract][Full Text] [Related]
56. Melanoma cell adhesion molecule stimulates yes-associated protein transcription by enhancing CREB activity via c-Jun/c-Fos in hepatocellular carcinoma cells.
Qiao Y; Qian Y; Wang J; Tang X
Oncol Lett; 2016 Jun; 11(6):3702-3708. PubMed ID: 27284374
[TBL] [Abstract][Full Text] [Related]
57. The TAZ-CAMTA1 Fusion Protein Promotes Tumorigenesis via Connective Tissue Growth Factor and Ras-MAPK Signaling in Epithelioid Hemangioendothelioma.
Ma S; Kanai R; Pobbati AV; Li S; Che K; Seavey CN; Hallett A; Burtscher A; Lamar JM; Rubin BP
Clin Cancer Res; 2022 Jul; 28(14):3116-3126. PubMed ID: 35443056
[TBL] [Abstract][Full Text] [Related]
58. Spatial range of autocrine signaling: modeling and computational analysis.
Shvartsman SY; Wiley HS; Deen WM; Lauffenburger DA
Biophys J; 2001 Oct; 81(4):1854-67. PubMed ID: 11566760
[TBL] [Abstract][Full Text] [Related]
59. Oncogenic signal transduction and therapeutic strategy for hepatocellular carcinoma.
Tanaka S; Sugimachi K; Maehara S; Harimoto N; Shirabe K; Wands JR; Sugimachi K
Surgery; 2002 Jan; 131(1 Suppl):S142-7. PubMed ID: 11821801
[TBL] [Abstract][Full Text] [Related]
60. [Study on the synthesis and secretion rate of transferrin in hepatoma and peritumor hepatocytes].
Xie T; Wu M; Shen F
Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):14-7. PubMed ID: 10743046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
